Feb 8 (Reuters) - BioSenic (Formerly Bone Therapeutics)
BIOS.BR :
* BIOSENIC ANNOUNCES APPROVAL, PUBLICATION OF PROSPECTUS FOR
LISTING, ADMISSION TO TRADING OF SHARES, SUBSCRIPTION RIGHTS
* BIOSENIC ANNOUNCES APPROVAL, PUBLICATION OF PROSPECTUS IN
CONNECTION WITH CAPITAL INCREASE BY CONTRIBUTION IN KIND OF
MEDSENIC'S 51% STAKE
* NEWLY ADMITTED SHARES, SUBSCRIPTION RIGHTS WILL BE LISTED,
AVAILABLE FOR TRADING ON EURONEXT BRUSSELS, EURONEXT PARIS BY
FRIDAY 10 FEBRUARY 2023
Source text for Eikon: ID:nGNE3vBhw7
Further company coverage: BIOS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))